Bioscience Animal Health PCL
SET:BIS
Bioscience Animal Health PCL
Total Equity
Bioscience Animal Health PCL
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bioscience Animal Health PCL
SET:BIS
|
Total Equity
฿802.1m
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
W
|
Winnergy Medical PCL
SET:WINMED
|
Total Equity
฿632.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
|
B
|
Business Alignment PCL
SET:BIZ
|
Total Equity
฿878.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
15%
|
|
|
T
|
Techno Medical PCL
SET:TM
|
Total Equity
฿407.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
E
|
E for L Aim PCL
SET:EFORL
|
Total Equity
฿576.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
|
S
|
SEI Medical PCL
SET:SEI
|
Total Equity
฿282.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bioscience Animal Health PCL
Glance View
Bioscience Animal Health Public Co. Ltd. engages in manufacturing, importing, and distribution of medical supplies, tools, equipment, and products for livestock and pets. The company is headquartered in Pak Kret, Nonthaburi. The company went IPO on 2022-05-05. The firm is an importer and distributor of medical supplies, tools, equipment and products for livestock and pets. The company focuses on selecting products by specialist veterinarians to improve animal health. The firm's products include antibiotic, additive, BiSMiX B-Series, BiSMiX SD Series, injection, mold inhibitor, water-soluble products, vaccine and certificate bioscience. The antibiotic includes Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. Its additive pHorce, orego-stim-powder, Optiphos, Moldgard, Mastercube and Lianol solapro. The injection consists of Zuprevo, Nuflor, Ceva and Enzaprost. The water-soluble products consist of Tilmosin AC, Surmox col and Coliscour. The firm's subsidiaries include Feed and Ingredients Technological Hub Co., Ltd., Special Ingredient Services Co., Ltd., and others.
See Also
What is Bioscience Animal Health PCL's Total Equity?
Total Equity
802.1m
THB
Based on the financial report for Dec 31, 2024, Bioscience Animal Health PCL's Total Equity amounts to 802.1m THB.
What is Bioscience Animal Health PCL's Total Equity growth rate?
Total Equity CAGR 3Y
45%
Over the last year, the Total Equity growth was 3%. The average annual Total Equity growth rates for Bioscience Animal Health PCL have been 45% over the past three years .
